It has been found that the combined production of the immunosuppressants IL-10 and TGF-β in patients with pulmonary tuberculosis may reduce host immunity against Mycobacterium tuberculosis, resulting in uncontrolled bacterial replication and causing overt disease (Bonecini-Almeida et al., 2004). Here, TGFB1 is linked to pulmonary tuberculosis.